Pinto C - Search Results

1

Phase II study on first-line treatment of NIVolumab in combination with folfoxiri/bevacizumab in patients with Advanced COloRectal cancer RAS or BRAF mutated - NIVACOR trial (GOIRC-03-2018).

Damato A, Iachetta F, Antonuzzo L, Nasti G, Bergamo F, Bordonaro R, Maiello E, Zaniboni A, Tonini G, Romagnani A, Berselli A, Normanno N, Pinto C. Damato A, et al. Among authors: pinto c. BMC Cancer. 2020 Aug 31;20(1):822. doi: 10.1186/s12885-020-07268-4. BMC Cancer. 2020. PMID: 32867715 Free PMC article.

2

Cigarettes smoking habit may reduce benefit from cetuximab-based treatment in advanced colorectal cancer patients.

Vincenzi B, Santini D, Loupakis F, Addeo R, Rojas Llimpe FL, Baldi GG, Di Fabio F, Del Prete S, Pinto C, Falcone A, Tonini G. Vincenzi B, et al. Among authors: pinto c. Expert Opin Biol Ther. 2009 Aug;9(8):945-9. doi: 10.1517/14712590903081694. Expert Opin Biol Ther. 2009. PMID: 19534585

3

Detection of KRAS mutations in colorectal carcinoma patients with an integrated PCR/sequencing and real-time PCR approach.

Carotenuto P, Roma C, Rachiglio AM, Tatangelo F, Pinto C, Ciardiello F, Nappi O, Iaffaioli RV, Botti G, Normanno N. Carotenuto P, et al. Among authors: pinto c. Pharmacogenomics. 2010 Aug;11(8):1169-79. doi: 10.2217/pgs.10.86. Pharmacogenomics. 2010. PMID: 20712532 Clinical Trial.

4

Management of skin toxicity associated with cetuximab treatment in combination with chemotherapy or radiotherapy.

Pinto C, Barone CA, Girolomoni G, Russi EG, Merlano MC, Ferrari D, Maiello E; American Society of Clinical Oncology; European Society of Medical Oncology. Pinto C, et al. Oncologist. 2011;16(2):228-38. doi: 10.1634/theoncologist.2010-0298. Epub 2011 Jan 27. Oncologist. 2011. PMID: 21273511 Free PMC article.

5

Phase II study of panitumumab, oxaliplatin, 5-fluorouracil, and concurrent radiotherapy as preoperative treatment in high-risk locally advanced rectal cancer patients (StarPan/STAR-02 Study).

Pinto C, Di Fabio F, Maiello E, Pini S, Latiano T, Aschele C, Garufi C, Bochicchio A, Rosati G, Aprile G, Giaquinta S, Torri V, Bardelli A, Gion M, Martoni A. Pinto C, et al. Ann Oncol. 2011 Nov;22(11):2424-2430. doi: 10.1093/annonc/mdq782. Epub 2011 Mar 8. Ann Oncol. 2011. PMID: 21385884 Free article. Clinical Trial.

6

KRAS mutations testing in colorectal carcinoma patients in Italy: from guidelines to external quality assessment.

Normanno N, Pinto C, Castiglione F, Bardelli A, Gambacorta M, Botti G, Nappi O, Siena S, Ciardiello F, Taddei G, Marchetti A. Normanno N, et al. Among authors: pinto c. PLoS One. 2011;6(12):e29146. doi: 10.1371/journal.pone.0029146. Epub 2011 Dec 21. PLoS One. 2011. PMID: 22216189 Free PMC article.

7

Comment on 'a comparison of three methods for detecting KRAS mutations in formalin-fixed colorectal cancer specimens'.

Normanno N, Rachiglio A, Roma C, Ciardiello F, Pinto C. Normanno N, et al. Among authors: pinto c. Br J Cancer. 2012 Nov 6;107(10):1791-2; author reply 1793-4. doi: 10.1038/bjc.2012.431. Epub 2012 Sep 25. Br J Cancer. 2012. PMID: 23011482 Free PMC article. No abstract available.

8

Results of the First Italian External Quality Assurance Scheme for somatic EGFR mutation testing in non-small-cell lung cancer.

Normanno N, Pinto C, Taddei G, Gambacorta M, Castiglione F, Barberis M, Clemente C, Marchetti A. Normanno N, et al. Among authors: pinto c. J Thorac Oncol. 2013 Jun;8(6):773-8. doi: 10.1097/JTO.0b013e31828c2b08. J Thorac Oncol. 2013. PMID: 23575414 Free article.

9

Panitumumab in combination with infusional oxaliplatin and oral capecitabine for conversion therapy in patients with colon cancer and advanced liver metastases. The MetaPan study.

Leone F, Artale S, Marino D, Cagnazzo C, Cascinu S, Pinto C, Fornarini G, Tampellini M, Di Fabio F, Sartore-Bianchi A, De Carlis L, Pugliese R, Capussotti L, Gioeni L, Siena S, Aglietta M. Leone F, et al. Among authors: pinto c. Cancer. 2013 Oct 1;119(19):3429-35. doi: 10.1002/cncr.28223. Epub 2013 Jul 18. Cancer. 2013. PMID: 23868516 Free article. Clinical Trial.

10

KRAS early testing: consensus initiative and cost-effectiveness evaluation for metastatic colorectal patients in an Italian setting.

Barone C, Pinto C, Normanno N, Capussotti L, Cognetti F, Falcone A, Mantovani L. Barone C, et al. Among authors: pinto c. PLoS One. 2014 Jan 20;9(1):e85897. doi: 10.1371/journal.pone.0085897. eCollection 2014. PLoS One. 2014. PMID: 24465771 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,604 results

Search Page